EP Patent

EP3560496A1 — Combination compositions for treating alzheimer disease and related disorders with zonisamide and acamprosate

Assigned to Pharnext SA · Expires 2019-10-30 · 7y expired

What this patent protects

The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that modulate synapse function for treating said disease.

USPTO Abstract

The present invention relates to compositions and methods for the treatment of Alzheimer's disease and related disorders. More particularly, the invention relates to combined therapies that modulate synapse function for treating said disease.

Drugs covered by this patent

Patent Metadata

Patent number: EP3560496A1
Jurisdiction: EP
Classification: —
Expires: 2019-10-30
Drug substance claim: No
Drug product claim: No
Assignee: Pharnext SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.